Zoledronate Causes a Systemic Shift of Macrophage Polarization towards M1 In Vivo
Background: Immunomodulatory properties of bisphosphonates (BP) are suggested to contribute to the development of medication-associated osteonecrosis of the jaw (MRONJ). Furthermore, bisphosphonate-derived immune modulation might contribute to the anti-metastatic effect observed in breast cancer pat...
Main Authors: | Manuel Weber, Andi Homm, Stefan Müller, Silke Frey, Kerstin Amann, Jutta Ries, Carol Geppert, Raimund Preidl, Tobias Möst, Peer W. Kämmerer, Marco Kesting, Falk Wehrhan |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/3/1323 |
Similar Items
-
Potential protective effect of zoledronic acid when switching from long-term therapy of osteoporosis with denosumab
by: O. V. Yakushevskaya
Published: (2021-01-01) -
Alterations in macrophage polarization in the craniofacial and extracranial skeleton after zoledronate application and surgical interventions – an in vivo experiment
by: Ann-Kristin Struckmeier, et al.
Published: (2023-05-01) -
Polyarthritis following infusion of zoledronic acid: a case study
by: T. Campbell
Published: (2023-07-01) -
Evaluation of Jaw Osteonecrosis Following Intra-Ligament Anesthesia in Zoledronate-Treated Rats: a Histological Evaluation
by: Saeed Moradi, et al.
Published: (2023-03-01) -
Spontaneous medication-related osteonecrosis of the jaws in a 23-year-Old
by: Brenden J. Manley, et al.
Published: (2023-03-01)